BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16201716)

  • 1. Fragile X syndrome: a clinico-genetic study of mentally retarded patients in Kuwait.
    Bastaki LA; Hegazy F; Al-Heneidi MM; Turki N; Azab AS; Naguib KK
    East Mediterr Health J; 2004; 10(1-2):116-24. PubMed ID: 16201716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical checklist for fragile X syndrome: screening of Thai boys with developmental delay of unknown cause.
    Limprasert P; Ruangdaraganon N; Vasiknanonte P; Sura T; Jaruratanasirikul S; Sriwongpanich N; Sriplung H
    J Med Assoc Thai; 2000 Oct; 83(10):1260-6. PubMed ID: 11143494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new PCR assay useful for screening of FRAXE/FMR2 mental impairment among males.
    Santos CB; Costa Lima MA; Pimentel MM
    Hum Mutat; 2001 Aug; 18(2):157-62. PubMed ID: 11462240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of FRAXE-positive subjects with mental impairement in two unrelated Italian families.
    Russo S; Selicorni A; Bedeschi MF; Natacci F; Viziello P; Fortuna R; Pagani G; Dalprà L; Larizza L
    Am J Med Genet; 1998 Jan; 75(3):304-8. PubMed ID: 9475603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of school children at high risk for fragile X syndrome utilizing buccal cell FMR-1 testing.
    Hagerman RJ; Wilson P; Staley LW; Lang KA; Fan T; Uhlhorn C; Jewell-Smart S; Hull C; Drisko J; Flom K
    Am J Med Genet; 1994 Jul; 51(4):474-81. PubMed ID: 7943023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for fragile X syndrome among Brazilian mentally retarded male patients using PCR from buccal cell DNA.
    Christofolini DM; Lipay MV; Ramos MA; Brunoni D; Melaragno MI
    Genet Mol Res; 2006 Jul; 5(3):448-53. PubMed ID: 17117359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical characteristics of fragile X syndrome at child development clinic, Ramathibodi Hospital.
    Ruangdaraganon N; Limprasert P; Sura T; Sombuntham T; Sriwongpanich N; Kotchabhakdi N
    J Med Assoc Thai; 2000 Jan; 83(1):69-76. PubMed ID: 10710872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic screening for fragile X syndrome in a cohort of 574 mentally retarded children.
    Gérard B; Le Heuzey MF; Brunie G; Lewine P; Saiag MC; Cacheux V; Da Silva F; Dugas M; Mouren-Simeoni MC; Elion J; Grandchamp B
    Ann Genet; 1997; 40(3):139-44. PubMed ID: 9401101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fragile X-syndrome and mental retardation].
    Eskeland P
    Tidsskr Nor Laegeforen; 1992 Mar; 112(8):1007-8. PubMed ID: 1553720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of expression of FMR-1 gene in male patients with fragile X syndrome using RT-PCR].
    Zhu W; Li M; Zhao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):17-9. PubMed ID: 9456366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FMRP detection assay for the diagnosis of the fragile X syndrome.
    Willemsen R; Oostra BA
    Am J Med Genet; 2000; 97(3):183-8. PubMed ID: 11449486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple multiplex FRAXA, FRAXE, and FRAXF PCR assay convenient for wide screening programs.
    Strelnikov V; Nemtsova M; Chesnokova G; Kuleshov N; Zaletayev D
    Hum Mutat; 1999; 13(2):166-9. PubMed ID: 10094554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG.
    Sermon K; Seneca S; Vanderfaeillie A; Lissens W; Joris H; Vandervorst M; Van Steirteghem A; Liebaers I
    Prenat Diagn; 1999 Dec; 19(13):1223-30. PubMed ID: 10660959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation.
    Pandey UB; Phadke S; Mittal B
    Genet Test; 2002; 6(4):335-9. PubMed ID: 12537661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive screening of fragile X syndrome A using urine and hair roots.
    Suwa K; Momoi MY
    Brain Dev; 2004 Sep; 26(6):380-3. PubMed ID: 15275700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The fragile X chromosome and psychiatry].
    Gherardi D; Garzia P; Fabrizio E; Chirillo S
    Minerva Psichiatr; 1992; 33(4):285-8. PubMed ID: 1297905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Direct molecular analysis of FMR-1 gene mutation in patients with fragile Xq syndrome and their families].
    Alliende MA; Urzúa B; Valiente A; Cortés F; Curotto B; Rojas C
    Rev Med Chil; 1998 Dec; 126(12):1435-46. PubMed ID: 10349157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.